Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.
about
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertensionThe Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease.Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions.Pharmacological treatment of HIV-associated pulmonary hypertension.Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.
P2860
Ambrisentan therapy in pulmonary hypertension: clinical use and tolerability in a referral centre.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@en
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@nl
type
label
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@en
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@nl
prefLabel
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@en
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@nl
P2093
P2860
P50
P356
P1476
Ambrisentan therapy in pulmona ...... rability in a referral centre.
@en
P2093
Catherine Billings
Charlie A Elliot
David G Kiely
Neil Hamilton
P2860
P356
10.1177/1753465814532304
P577
2014-04-30T00:00:00Z